Back to Search
NATHAN OLDHAM, M.D.
M.D.
Family Medicine Physician
NPI: 1780883843IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
11013781(IN)036125954(IL)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE
Class of 2007
Research & Publications (20)
The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) project: an open-label pragmatic randomised control trial comparing the efficacy of differing therapeutic agents for primary care detoxification from either street heroin or methadone [ISRCTN07752728].
PMID 15117415·BMC Fam Pract·2004
3-trial
Non-denaturing electrospray ionisation-mass spectrometry reveals ligand selectivity in histamine-binding protein RaHBP2.
PMID 14649894·Org Biomol Chem·2003
8-other
Site-selective chemical protein glycosylation protects from autolysis and proteolytic degradation.
PMID 19608158·Carbohydr Res·2009
8-other
Collision induced unfolding of protein ions in the gas phase studied by ion mobility-mass spectrometry: the effect of ligand binding on conformational stability.
PMID 19643633·J Am Soc Mass Spectrom·2009
7-preclinical
ESI-MS studies on prolyl hydroxylase domain 2 reveal a new metal binding site.
PMID 18058781·ChemMedChem·2008
8-other
Evaluation of aspirin metabolites as inhibitors of hypoxia-inducible factor hydroxylases.
PMID 19048166·Chem Commun (Camb)·2008
8-other
Buprenorphine versus dihydrocodeine for opiate detoxification in primary care: a randomised controlled trial.
PMID 17210079·BMC Fam Pract·2007
4-observational
Combined mass spectrometry and dynamic chemistry approach to identify metalloenzyme inhibitors.
PMID 17206734·ChemMedChem·2007
8-other
Quantitative determination of lysozyme-ligand binding in the solution and gas phases by electrospray ionisation mass spectrometry.
PMID 17922488·Rapid Commun Mass Spectrom·2007
7-preclinical
Expanding the diversity of chemical protein modification allows post-translational mimicry.
PMID 17460675·Nature·2007
7-preclinical
Asparaginyl hydroxylation of the Notch ankyrin repeat domain by factor inhibiting hypoxia-inducible factor.
PMID 17573339·J Biol Chem·2007
8-other
Bile acid interactions with rabbit ileal lipid binding protein and an engineered helixless variant reveal novel ligand binding properties of a versatile beta-clam shell protein scaffold.
PMID 17618650·J Mol Biol·2007
7-preclinical
Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates.
PMID 17135241·J Biol Chem·2007
8-other
Purified recombinant hARD1 does not catalyse acetylation of Lys532 of HIF-1alpha fragments in vitro.
PMID 16500650·FEBS Lett·2006
8-other
Studies on ternary metallo-beta lactamase-inhibitor complexes using electrospray ionization mass spectrometry.
PMID 16713713·J Am Soc Mass Spectrom·2006
8-other
Cellular oxygen sensing: Crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2).
PMID 16782814·Proc Natl Acad Sci U S A·2006
8-other
Posttranslational hydroxylation of ankyrin repeats in IkappaB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH).
PMID 17003112·Proc Natl Acad Sci U S A·2006
8-other
Homeless drug users' awareness and risk perception of peer "take home naloxone" use--a qualitative study.
PMID 17014725·Subst Abuse Treat Prev Policy·2006
8-other
Hypoxia-inducible factor prolyl hydroxylase 2 has a high affinity for ferrous iron and 2-oxoglutarate.
PMID 16880998·Mol Biosyst·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1201 PINE ST
ELDORADO, IL 62930 - Phone
- (618) 297-9665
Quick Facts
- NPI
- 1780883843
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 19
- Publications
- 20
Are you this provider?
Claim Your Profile